Vertex Pharmaceuticals Incorporated Stock Forecast
Green day on Thursday for Vertex Pharmaceuticals Incorporated
(Updated on Apr 18, 2024)
The Vertex Pharmaceuticals Incorporated stock price gained 0.0967% on the last trading day (Thursday, 18th Apr 2024), rising from $393.10 to $393.48. During the last trading day the stock fluctuated 1.31% from a day low at $391.02 to a day high of $396.14. The price has been going up and down for this period, and there has been a -2.61% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 63 thousand more shares were traded than the day before. In total, 943 thousand shares were bought and sold for approximately $371.04 million.
The stock lies in the lower of a falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $392.53 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -7.88% during the next 3 months and, with a 90% probability hold a price between $361.58 and $381.92 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
VRTX Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 0.0967%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Vertex Pharmaceuticals Incorporated stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $396.07 and $410.17. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Vertex Pharmaceuticals Incorporated stock
Vertex Pharmaceuticals Incorporated finds support from accumulated volume at $393.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $5.12 (1.31%) between high and low. For the last week, the stock has had daily average volatility of 1.48%.
Vertex Pharmaceuticals Incorporated is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (VRTX) For The Upcoming Trading Day Of Friday 19th
For the upcoming trading day on Friday, 19th we expect Vertex Pharmaceuticals Incorporated to open at $393.55, and during the day (based on 14 day Average True Range), to move between $386.34 and $400.62, which gives a possible trading interval of +/-$7.14 (+/-1.81%) up or down from last closing price. If Vertex Pharmaceuticals Incorporated takes out the full calculated possible swing range there will be an estimated 3.63% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $393.10 (0.10%) than the resistance at $416.13 (5.76%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Vertex Pharmaceuticals Incorporated stock A Buy?
Vertex Pharmaceuticals Incorporated holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -2.623 Sell Candidate Unchanged
Predicted Opening Price for Vertex Pharmaceuticals Incorporated of Friday, April 19, 2024
| Fair opening price April 19, 2024 | Current price |
|---|---|
| $393.55 ( 0.0169%) | $393.48 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for VRTX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 398.67 | 1.32 % | |
| R2 | 396.71 | 0.82 % | ||
| R1 | 395.50 | 0.514 % | ||
| Current price: | 393.48 | |||
| Support | S1 | 391.59 | -0.480 % | |
| S2 | 390.38 | -0.787 % | ||
| S3 | 388.43 | -1.28 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 446.08 | 13.37 % | |
| R2 | 433.38 | 10.14 % | ||
| R1 | 416.13 | 5.76 % | ||
| Current price | 393.48 | |||
| Support | S1 | 393.10 | -0.0966% | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Vertex Pharmaceuticals Incorporated Stock.
